Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

Breast cancer (BC) is the most common malignancy affecting women. It is a highly heterogeneous disease broadly defined by the differential expression of cell surface receptors. In the United States, triple negative breast cancer (TNBC) represents 15 to 20% of all BC. When compared with other subtype...

Full description

Bibliographic Details
Main Authors: Maroun Bou Zerdan, Tala Ghorayeb, Fares Saliba, Sabine Allam, Morgan Bou Zerdan, Marita Yaghi, Nadeem Bilani, Rola Jaafar, Zeina Nahleh
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
triple negative breast neoplasms
Poly (ADP-ribose) polymerase inhibitors
immune checkpoint inhibitors
immunoconjugates
Online Access:https://www.mdpi.com/2072-6694/14/5/1253

Internet

https://www.mdpi.com/2072-6694/14/5/1253

Similar Items